| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2023 | Jan 27, 2023 | York Michael Chief Business Officer | Sell | Metacrine, Inc. | MTCR | $0.41 | $44,331 | -50.84% |
| Dec 11, 2018 | Dec 11, 2018 | York Michael VP Corporate Development | Buy | Phasebio Pharmaceuticals Inc | PHAS | $3.88 | $5,820 | +50.00% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.